Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

    Receive Latest News

    Share Us

    Translational Immunology

    View: 74

    Website | Edit Freely

    Category translational immunology, Translational Gastroenterology, Immunopathology, Immunopathogenesis, Immune-mediated disorders or immunomediated disorders, Immune-mediated diseases or immunomediated diseases, Precision medicine, Personalised medicine, Mucosal immunology, Tumor immunology, Cancer immunology, Cancer immunotherapy, Immuno-oncology,

    Deadline: October 27, 2020 | Date: December 08, 2020-December 09, 2020

    Venue/Country: GHENT, Belgium

    Updated: 2020-06-17 18:03:23 (GMT+9)

    Call For Papers - CFP

    Translational Immunology


    Due to the Coronavirus, Translational Immunology and the satellite BIS meeting were postponed from 26-27 March 2020 to the end of the year. We are happy to confirm the new date: 8-9 December 2020.

    The aim of this conference is to bridge the translational gap in immunopathology, bringing together clinicians, research scientists and industry partners to discuss prominent advances from the bench to the clinic. The different sessions will have a particular focus on precision medicine in general, starting from disease-oriented cases and lessons learned. Innovative and alternative therapeutic strategies in immune-mediated disorders will be presented, besides the regulatory challenges that companies and researchers are dealing with.


    - Abstract submission: 5 October 2020

    - Early Bird deadline: 27 October 2020

    - Late Registration deadline: 24 November 2020


    Rosa Bacchetta Stanford Medicine, US

    Dirk Elewaut VIB-UGent Center for Inflammation Research, BE

    Alain Fischer Assistance publique – Hôpitaux de Paris, FR

    Martin Guilliams VIB-UGent Center for Inflammation Research, BE

    Pleun Hombrink Sanquin, NL

    Bengt Hoepken Clinical Program Director, UCB Pharma, DE

    Isabelle Huys KU Leuven, BE

    Christophe Lahorte National Innovation Office & Scientific-Technical Advice Unit - (Famhp), BE

    Bart Lambrecht VIB-UGent Center for Inflammation Research, BE

    Antonio Lanzavecchia Institute for Research in Biomedicine, CH

    Sophie Lucas de Duve Institute, UCLouvain, BE

    Bénédicte Machiels FARAH Center, ULiège, BE

    Melanie Matheu CEO, Founder at Prellis Biologics, Inc., US

    Massimiliano Mazzone VIB-KU Leuven Center for Cancer Biology, BE

    Kathy McCoy University of Calgary, CA

    Eoin McKinney University of Cambridge, UK

    Fiona Powrie Kennedy Institute of Rheumatology, University of Oxford, UK

    Federica Sallusto Institute for Research in Biomedicine, CH

    Georg Schett Friedrich-Alexander University Erlangen-Nürnberg, DE

    Marvin van Luijn Erasmus MC, University Medical Center Rotterdam MS Center ErasMS, NL

    Location: De Bijloke, Jozef Kluyskensstraat 2, 9000 Gent

    Hashtag: #TransImmu20

    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.